Innovations in the quantitative virus outgrowth assay and its use in clinical trials.

about

Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock Strategies.

P2860

Q52431127-B3851840-10F3-4284-AE4B-200A67D1A509

P2860

Innovations in the quantitative virus outgrowth assay and its use in clinical trials.

Item

http://www.wikidata.org/entity/Q47153987

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Innovations in the quantitative virus outgrowth assay and its use in clinical trials.

@en

Innovations in the quantitative virus outgrowth assay and its use in clinical trials.

@nl

type

Item

label

Innovations in the quantitative virus outgrowth assay and its use in clinical trials.

@en

Innovations in the quantitative virus outgrowth assay and its use in clinical trials.

@nl

prefLabel

Innovations in the quantitative virus outgrowth assay and its use in clinical trials.

@en

Innovations in the quantitative virus outgrowth assay and its use in clinical trials.

@nl

P1476

Innovations in the quantitative virus outgrowth assay and its use in clinical trials

@en

P2093

Andrew M L Lever

http://www.w3.org/2001/XMLSchema#string

Axel Fun

http://www.w3.org/2001/XMLSchema#string

Mikaila Bandara

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Ongoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory Agents

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations

HIV-1 expression within resting CD4+ T cells after multiple doses of vorinostat

Valproic acid in association with highly active antiretroviral therapy for reducing systemic HIV-1 reservoirs: results from a multicentre randomized clinical study.

Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay

P2888

s12977-017-0381-2

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1186/S12977-017-0381-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hoi Ping Mok

Mark R Wills

Nicholas J Norton

P5008

ScienceSource

P577

2017-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1099749090

http://www.w3.org/2001/XMLSchema#string

P698

29268753

http://www.w3.org/2001/XMLSchema#string

P921

human immunodeficiency virus infectious disease

Retroviridae infectious disease

biomedical investigative technique

hemic and immune systems

Achyolli

Añaw

P932

5740843

http://www.w3.org/2001/XMLSchema#string

Innovations in the quantitative virus outgrowth assay and its use in clinical trials.

about

P2860

P2860

Innovations in the quantitative virus outgrowth assay and its use in clinical trials.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P50

P5008

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P50

P5008

P577

P6179

P698

P921

P932